Showing results (171-180 of 1,988) with videos related to
Sort By:
Pageof 199
Oncology Research and Treatment|July 26, 2022
Efficacy and Safety of Bevacizumab in Pretreated Metastatic Breast Cancer: A Systematic Review and Meta-AnalysisZhijun Li, Fengzhu Guo, Yiqun Han, et al.Scientific Reports|February 7, 2017
The Demographic Features, Clinicopathological Characteristics and Cancer-specific Outcomes for Patients with Microinvasive Breast Cancer: A SEER Database AnalysisWenna Wang, Wenjie Zhu, Feng Du, et al.Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer|December 29, 2017
Relationship between Topoisomerase II Alpha Overexpression and Prognosis in Chinese Gastric Cancer PatientsFangchao Zheng, Jiuda Zhao, Feng Du, et al.Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 12, 2026
Factors associated with neoadjuvant therapy insensitivity and its prognostic impact in HER2-positive breast cancerYuhang Han, Bo Lan, Zexi Peng, et al.The Journal of Physical Chemistry. B|November 6, 2018
Dynamics and Coherent Control of Exciton-Exciton Annihilation in Aqueous J-AggregateFei MaTherapeutic Advances in Medical Oncology|January 5, 2026
Efficacy and safety of PARP inhibitors in metastatic breast cancer patients with homologous recombination repair pathway gene mutations: a retrospective multicenter real-world studyXuenan Peng, Ruixia Song, Ying Fan, et al.Heliyon|October 10, 2024
The different sequences of CDK4/6 inhibitor and mTOR inhibitor in HR+/HER2-advanced breast cancer: A multicenter real-world studyYuqian Liao, Yujing Tan, Yipeng Li, et al.The Oncologist|February 6, 2026
Efficacy of neoadjuvant endocrine therapy with CDK4/6 inhibitors in locally advanced breast cancerMengqi Zhang, Mingxiao Li, Shihan Zhou, et al.Journal of Environmental and Public Health|October 6, 2022
Entrepreneurial Willingness, Practice, and Management Path of College Graduates in a Green Development EnvironmentFei MaFrontiers in Oncology|July 5, 2022
Clinicopathological Characteristics and Prognosis of HER2-Low Early-Stage Breast Cancer: A Single-Institution ExperienceHangcheng Xu, Yiqun Han, Yun Wu, et al.Pageof 199